New MRI Finding Sheds Light On Multiple Sclerosis Disease Progression - Study Results Appear In The September Issue Of Radiology
Estrogen That Protects The Brain Without Increasing Cancer Risk May Treat MS
Small Phase 2 Study Of Daclizumab Shows Benefit Alone And In Combination With Interferon
Tysabri Approved By NICE, UK
Estrogen That Protects The Brain Without Increasing Cancer Risk May Treat MS
Small Phase 2 Study Of Daclizumab Shows Benefit Alone And In Combination With Interferon
Tysabri Approved By NICE, UK
0 Comments:
Post a Comment
<< Home